Dr.Min JeongPark South Korea

I received my MD and PhD from the College of Medicine, Korea University. After completing fellowship training in Endocrinology and Metabolism at Korea University Hospital and Seoul National University Hospital, I joined the faculty at Korea University Guro Hospital, where I am currently an Assistant Professor in the Division of Endocrinology and Metabolism.

22 MARCH

Time	Session

11:00 12:30	ESROC-KES Joint Symposium Updates in Endocrinology: Emerging Insights into Adrenal Disorders, Muscle Health, and Endocrine Diseases Pheochromocytoma: Current Concepts and Emerging Evidence Min Jeong ParkSouth Korea Speaker Pheochromocytoma: Current Concepts and Emerging Evidence Translational Research for Developing Blood-Based Biomarkers of Sarcopenia Beom-Jun KimSouth Korea Speaker Translational Research for Developing Blood-Based Biomarkers of Sarcopenia Anxiety in Patients with Thyroid Nodules: What Clinicians Need to Know Edy KorneliusTaiwan Speaker Anxiety in Patients with Thyroid Nodules: What Clinicians Need to KnowThyroid nodules are commonly encountered in endocrine practice, and while the majority are benign, the diagnostic and surveillance process often imposes a substantial psychological burden on patients. Anxiety related to fear of malignancy, uncertainty surrounding ultrasonographic findings, fine-needle aspiration results, and long-term follow-up is frequently underestimated and insufficiently addressed in routine clinical care. Emerging evidence suggests that anxiety in patients with thyroid nodules may persist even after reassurance of benign disease and can significantly affect quality of life, healthcare utilization, and decision-making preferences. Cancer-related worry is often disproportionate to the actual risk of malignancy and may be exacerbated by repeated imaging, indeterminate cytology, ambiguous terminology, and lack of clear follow-up strategies. Heightened anxiety has been associated with increased demand for diagnostic interventions and preference for aggressive management, potentially leading to overtreatment. This presentation reviews current evidence on the prevalence, determinants, and clinical consequences of anxiety among patients with thyroid nodules, integrating published literature with real-world clinical experience. Practical approaches for identifying psychological distress in outpatient settings and strategies for improving communication and expectation management will be discussed. Recognizing and addressing anxiety as an integral component of thyroid nodule care is essential for delivering holistic, patient-centred, and value-based endocrinology. Impaired Fasting Glucose and Musculoskeletal Disorders Yi-Sun YangTaiwan Speaker Impaired Fasting Glucose and Musculoskeletal Disorders Discussion 103

Time

Session

11:00

12:30

ESROC-KES Joint Symposium

Updates in Endocrinology: Emerging Insights into Adrenal Disorders, Muscle Health, and Endocrine Diseases

Pheochromocytoma: Current Concepts and Emerging Evidence

Min Jeong ParkSouth Korea Speaker Pheochromocytoma: Current Concepts and Emerging Evidence
Translational Research for Developing Blood-Based Biomarkers of Sarcopenia

Beom-Jun KimSouth Korea Speaker Translational Research for Developing Blood-Based Biomarkers of Sarcopenia
Anxiety in Patients with Thyroid Nodules: What Clinicians Need to Know

Edy KorneliusTaiwan Speaker Anxiety in Patients with Thyroid Nodules: What Clinicians Need to KnowThyroid nodules are commonly encountered in endocrine practice, and while the majority are benign, the diagnostic and surveillance process often imposes a substantial psychological burden on patients. Anxiety related to fear of malignancy, uncertainty surrounding ultrasonographic findings, fine-needle aspiration results, and long-term follow-up is frequently underestimated and insufficiently addressed in routine clinical care. Emerging evidence suggests that anxiety in patients with thyroid nodules may persist even after reassurance of benign disease and can significantly affect quality of life, healthcare utilization, and decision-making preferences. Cancer-related worry is often disproportionate to the actual risk of malignancy and may be exacerbated by repeated imaging, indeterminate cytology, ambiguous terminology, and lack of clear follow-up strategies. Heightened anxiety has been associated with increased demand for diagnostic interventions and preference for aggressive management, potentially leading to overtreatment. This presentation reviews current evidence on the prevalence, determinants, and clinical consequences of anxiety among patients with thyroid nodules, integrating published literature with real-world clinical experience. Practical approaches for identifying psychological distress in outpatient settings and strategies for improving communication and expectation management will be discussed. Recognizing and addressing anxiety as an integral component of thyroid nodule care is essential for delivering holistic, patient-centred, and value-based endocrinology.
Impaired Fasting Glucose and Musculoskeletal Disorders

Yi-Sun YangTaiwan Speaker Impaired Fasting Glucose and Musculoskeletal Disorders
Discussion

103